Presentation is loading. Please wait.

Presentation is loading. Please wait.

Protective effect of magnesium on the endothelial function mediated by endothelium- derived hyperpolarizing factor in coronary arteries during cardioplegic.

Published byHadi Oesman Modified over 5 years ago

Similar presentations

Presentation on theme: "Protective effect of magnesium on the endothelial function mediated by endothelium- derived hyperpolarizing factor in coronary arteries during cardioplegic."— Presentation transcript:

1 Protective effect of magnesium on the endothelial function mediated by endothelium- derived hyperpolarizing factor in coronary arteries during cardioplegic arrest in a porcine model  Qin Yang, MD, MPH, Yao-Chung Liu, MD, Wei Zou, MD, Anthony P.C. Yim, MD, Guo-Wei He, MD, PhD  The Journal of Thoracic and Cardiovascular Surgery  Volume 124, Issue 2, Pages (August 2002) DOI: /mtc Copyright © 2002 American Association for Thoracic Surgery Terms and Conditions

2 Fig. 1 Change in resting force in porcine coronary microarteries during incubation with Krebs solution (control, subgroup Ia, filled circles) or solution containing 20-mmol/L potassium ion (subgroup Ib, open circles), 16-mmol/L magnesium ion (subgroup Ic, filled squares), or 20-mmol/L potassium ion plus 16 mmol/L magnesium ion (subgroup Id, open squares). Four rings taken from same microartery were allocated in four chambers of myograph, n = 8 in each group. Triple asterisk indicates P <.001 vs Krebs solution by ANOVA and Scheffé F test. The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /mtc ) Copyright © 2002 American Association for Thoracic Surgery Terms and Conditions

3 Fig. 2 Mean contraction force response to U46619 (range −8 to −7 log mol/L, see Methods section) after exposure to Krebs solution (control, subgroup Ia) or solution containing 20-mmol/L potassium ion (subgroup Ib, K20), 16-mmol/L magnesium ion (subgroup Ic, Mg16), or potassium ion plus magnesium ion (subgroup Id, K20+Mg16) for 1 hour in groups I (A) and III (B). Four rings taken from same microartery were allocated in four chambers of myograph, n = 8 in each group. A, P <.001 among 4 subgroups by ANOVA, but P >.05 for subgroups Ib, Ic, and Id compared with Krebs solution (control subgroup) by ANOVA and Scheffé F test. B, P >.05 among 4 subgroups. The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /mtc ) Copyright © 2002 American Association for Thoracic Surgery Terms and Conditions

4 Fig. 3 Concentration-relaxation curves for bradykinin (A, group I) and SNP (B, group II) in U46619-precontracted porcine coronary microarteries. Bradykinin-induced relaxation was performed with presence of indomethacin (7 μmol/L), l-NNA (300 μmol/L), and oxyhemoglobin (20 μmol/L) after exposure to following solutions for 1 hour: subgroup Ia or IIa (control, filled circles), Krebs solution; subgroup Ib or IIb (open circles), solution containing 20-mmol/L potassium ion; subgroup Ic or IIc (filled squares), solution containing 16-mmol/L magnesium ion; and subgroup Id or IId (open squares), solution containing 20-mmol/L potassium ion plus 16-mmol/L magnesium ion. Four rings taken from same microartery were allocated in four chambers of myograph; n = 8 in each subgroup. Asterisk indicates P <.05 compared with control subgroup by ANOVA and Scheffé F test; double asterisk indicates P <.01. The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /mtc ) Copyright © 2002 American Association for Thoracic Surgery Terms and Conditions

5 Fig. 4 Concentration-relaxation curves for bradykinin (group III) in U46619-precontracted porcine coronary microarteries with presence of indomethacin (7 μmol/L), l-NNA (300 μmol/L), and oxyhemoglobin (20 μmol/L) after exposure to following solutions for 1 hour followed by 45-minute washout: subgroup IIIa (control, filled circles), Krebs solution; subgroup IIIb (open circles), solution containing 20-mmol/L potassium ion; subgroup IIIc (filled squares), solution containing 16-mmol/L magnesium ion; and subgroup IIId (open squares), solution containing 20-mmol/L potassium ion plus 16-mmol/L magnesium ion. Four rings taken from same microartery were allocated in four chambers of myograph; n = 8 in each subgroup. The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /mtc ) Copyright © 2002 American Association for Thoracic Surgery Terms and Conditions

6 Fig. 5 Mean membrane potential of smooth muscle cells of porcine coronary arteries in presence of indomethacin (7 μmol/L) and l-NNA (300 μmol/L) after superfusion for 1 hour with solution containing 20-mmol/L potassium ion (subgroup IVa, n = 7, K20), solution containing 16-mmol/L magnesium ion (subgroup IVb, n = 6, Mg16), or solution containing 20-mmol/L potassium ion plus 16-mmol/L magnesium ion (subgroup IVc, n = 6, K20+Mg16). Triple asterisk indicates P <.001 versus control subgroup (before superfusion) by paired t test. The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /mtc ) Copyright © 2002 American Association for Thoracic Surgery Terms and Conditions

7 Fig. 6 Membrane potential measurement of smooth muscle cells of porcine coronary arteries. Concentration-response (membrane potential) curves for bradykinin (A-C) in presence of indomethacin (7 μmol/L) and l-NNA (300 μmol/L) after superfusion for 1 hour. A, Superfusion with solution containing 20-mmol/L potassium ion (subgroup IVa, n = 7, open circles). B, Superfusion with solution containing 16-mmol/L magnesium ion (subgroup IVb, n = 6, open circles). C, Superfusion with solution containing 20-mmol/L potassium ion plus 16 mmol/magnesium ion (subgroup IVc, n = 6, open circles). D, Change of membrane potential to bradykinin (−6.5 log mol/L). Asterisk indicates P <.05 vs control subgroup (before superfusion) by paired t test; double asterisk indicates P <.01; double pound sign indicates p <.01 vs 20-mmol/L potassium by unpaired t test. The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /mtc ) Copyright © 2002 American Association for Thoracic Surgery Terms and Conditions

Download ppt "Protective effect of magnesium on the endothelial function mediated by endothelium- derived hyperpolarizing factor in coronary arteries during cardioplegic."

Similar presentations

The coronary delivery of marrow stromal cells for myocardial regeneration: Pathophysiologic and therapeutic implications Jih-Shiuan Wang, MD, Dominique.

The coronary delivery of marrow stromal cells for myocardial regeneration: Pathophysiologic and therapeutic implications Jih-Shiuan Wang, MD, Dominique.
Resection of ascending aortic aneurysm without use of an interposition aortic graft John S. Ikonomidis, MD, PhD, FRCS(C), Abe DeAnda, MD, D.Craig Miller,

Resection of ascending aortic aneurysm without use of an interposition aortic graft John S. Ikonomidis, MD, PhD, FRCS(C), Abe DeAnda, MD, D.Craig Miller,
Urokinase treatment preserves endothelial and smooth muscle function in experimental acute arterial thrombosis  David Whitley, MD, Peter Gloviczki, MD,

Urokinase treatment preserves endothelial and smooth muscle function in experimental acute arterial thrombosis  David Whitley, MD, Peter Gloviczki, MD,
Effect of 11,12-epoxyeicosatrienoic acid as an additive to st

Effect of 11,12-epoxyeicosatrienoic acid as an additive to st
Limitation of thrombin generation, platelet activation, and inflammation by elimination of cardiotomy suction in patients undergoing coronary artery bypass.

Limitation of thrombin generation, platelet activation, and inflammation by elimination of cardiotomy suction in patients undergoing coronary artery bypass.
Total arterial revascularization of triple vessel coronary disease based on combined internal thoracic and radial artery grafts  Robert H. Habib, PhD,

Total arterial revascularization of triple vessel coronary disease based on combined internal thoracic and radial artery grafts  Robert H. Habib, PhD,
Propionyl-L-carnitine dilates human subcutaneous arteries through an endothelium- dependent mechanism  Marilyn J. Cipolla, PhD, Alexander Nicoloff, MD,

Propionyl-L-carnitine dilates human subcutaneous arteries through an endothelium- dependent mechanism  Marilyn J. Cipolla, PhD, Alexander Nicoloff, MD,
Heparin inhibits thrombin-induced mitogen-activated protein kinase signaling in arterial smooth muscle cells  Ulf Hedin, MD, PhD, Günter Daum, PhD, Alexander.

Heparin inhibits thrombin-induced mitogen-activated protein kinase signaling in arterial smooth muscle cells  Ulf Hedin, MD, PhD, Günter Daum, PhD, Alexander.
Use of intermediate/small conductance calcium-activated potassium-channel activator for endothelial protection  Qin Yang, MD, PhD, Jun-Hao Huang, MPhil,

Use of intermediate/small conductance calcium-activated potassium-channel activator for endothelial protection  Qin Yang, MD, PhD, Jun-Hao Huang, MPhil,
Myocardial protection with oxygenated esmolol cardioplegia during prolonged normothermic ischemia in the rat  Ryuzo Bessho, MD, PhD, David J. Chambers,

Myocardial protection with oxygenated esmolol cardioplegia during prolonged normothermic ischemia in the rat  Ryuzo Bessho, MD, PhD, David J. Chambers,
Growth hormone–releasing peptide ghrelin inhibits homocysteine-induced endothelial dysfunction in porcine coronary arteries and human endothelial cells 

Growth hormone–releasing peptide ghrelin inhibits homocysteine-induced endothelial dysfunction in porcine coronary arteries and human endothelial cells 
Endothelial nitric oxide synthase enhancer for protection of endothelial function from asymmetric dimethylarginine–induced injury in human internal thoracic.

Endothelial nitric oxide synthase enhancer for protection of endothelial function from asymmetric dimethylarginine–induced injury in human internal thoracic.
Cellular electrophysiologic and mechanical evidence of superior vascular protection in pulmonary microcirculation by Perfadex compared with Celsior  Min.

Cellular electrophysiologic and mechanical evidence of superior vascular protection in pulmonary microcirculation by Perfadex compared with Celsior  Min.
Altered coronary microvascular serotonin receptor expression after coronary artery bypass grafting with cardiopulmonary bypass  Michael P. Robich, MD,

Altered coronary microvascular serotonin receptor expression after coronary artery bypass grafting with cardiopulmonary bypass  Michael P. Robich, MD,
Wei Zhou, MD, Hong Chai, MD, PhD, Peter H. Lin, MD, Alan B

Wei Zhou, MD, Hong Chai, MD, PhD, Peter H. Lin, MD, Alan B
Volume 116, Issue 2, Pages (February 1999)

Volume 116, Issue 2, Pages (February 1999)
Endothelium-Dependent Vasoconstriction in Isolated Vessel Grafts: A Novel Mechanism of Vasospasm?  Markus Hoenicka, PhD, Andreas Keyser, MD, Leopold Rupprecht,

Endothelium-Dependent Vasoconstriction in Isolated Vessel Grafts: A Novel Mechanism of Vasospasm?  Markus Hoenicka, PhD, Andreas Keyser, MD, Leopold Rupprecht,
Vasorelaxation Induced by New Third-Generation Dihydropyridine Calcium Antagonist Azelnidipine in Human Internal Mammary Artery  Ge Gao, MD, PhD, Xiao-Cheng.

Vasorelaxation Induced by New Third-Generation Dihydropyridine Calcium Antagonist Azelnidipine in Human Internal Mammary Artery  Ge Gao, MD, PhD, Xiao-Cheng.
Activation of canonical transient receptor potential channels preserves Ca2+ entry and endothelium-derived hyperpolarizing factor–mediated function in vitro.

Activation of canonical transient receptor potential channels preserves Ca2+ entry and endothelium-derived hyperpolarizing factor–mediated function in vitro.
Effect of Benidipine in Human Internal Mammary Artery and Clinical Implications  Hai-Tao Hou, BE, Jun Wang, BA, Zheng-Qing Wang, MD, Xiao-Cheng Liu, MD,

Effect of Benidipine in Human Internal Mammary Artery and Clinical Implications  Hai-Tao Hou, BE, Jun Wang, BA, Zheng-Qing Wang, MD, Xiao-Cheng Liu, MD,

Similar presentations

Ads by Google